Leinco Technologies Forms Scientific Advisory Board to Advance Biomedical Innovation
Renowned Experts Dr. Robert Schreiber and Dr. Garry Nolan Join as Inaugural Members St. Louis, MO — September 29th, 2025 — Leinco Technologies, a leader in antibody and protein development, is pleased to announce the formation [...]
Leinco Technologies Acquires BioClin, Inc.’s Essential IVD Raw Material Antibody Clones, Bolstering Leinco’s IVD Raw Material Catalog Business
Saint Louis, MO – July 7, 2025 Leinco Technologies, a leading global provider of in vitro diagnostic (IVD) raw materials, today announced the acquisition of BioClin, Inc.’s proprietary antibody clones used as IVD raw materials. [...]
Message from Leinco Technologies: Antibody Pricing Stability Amid Market Shifts
St. Louis, MO, 17 June, 2025 - Leinco Technologies remains committed to supporting the global scientific community by ensuring consistent access to high-quality recombinant antibodies and reagents—without unexpected price increases. As tariffs and international trade [...]
Leinco Technologies Launches Groundbreaking ADAPT-3D™ Tissue Clearing Kit to Accelerate 3D Fluorescence Imaging
St. Louis, MO, 25 April, 2025 - Leinco Technologies, a leading innovator in life science research and diagnostic solutions, is proud to announce the launch of its ADAPT-3D Tissue Clearing Kit. This new offering is [...]
Leinco Technologies Awarded $1M Grant to Develop Rapid Test for Intestinal Immunity to Polio
St. Louis, MO, February 6, 2025 - Leinco Technologies, a leader in antibody and protein development, is thrilled to announce that it has been awarded a $1M grant from the Gates Foundation. The grant aims [...]
Leinco Technologies Welcomes Dr. Stephen T. Haley as Vice President of Business Development
St. Louis, MO, December 3, 2024 - Leinco Technologies is proud to announce the appointment of Dr. Stephen T. Haley as our new Vice President of Business Development. Dr. Haley brings over 20 years of [...]
